home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Targeting Mitochondrial Dysfunction & Toxicity

 
  October 25, 2013  
     
 
Omni Parker House, Boston, MA, USA
March 19-20, 2014


Session Titles Include:

  • Mitochondrial Allostatic Load and Therapeutic Windows
  • Mitochondrial Movement and Mood Stabilizer Treatment
  • Postnatal Neurogenesis Generates Oxidative Stress
  • Isolated Normal Mitochondrial Organelle Transplantation to Cancer Cells
  • Targeting Mitochondria Function for the Treatment of Breast Cancer
  • Mitochondria Are at the Center of Islet Beta-Cell Signaling and Metabolism-Secretion Coupling
  • Identification of a Mitochondrial Target of Thiazolidinedione Insulin Sensitizers (mTOT): Relationship to Newly Identified Mitochondrial Pyruvate Carrier Proteins
  • In Vitro Approaches to Assess Mitochondrial Toxicity and Mitochondria-Mediated Drug Toxicity: A Decade of Learning
  • Novel Tools to Assess Mitochondrial Toxicity under Physiological Conditions
Short Course: Imaging of Mitochondria
New methods of imaging of mitochondria and their processes have emerged recently. These new methods allow in vivo examination of the cells. This short course will explore some of the most innovative and newest methods for seeing into the "cell engines" and visualizing their operations for better understanding of them. 
 
 
Organized by: Cambridge Healthtech Institute (CHI)
Invited Speakers:

Speakers Include:

  • Martin Picard, Ph.D., Post-Doctoral Researcher, Center for Mitochondrial and Epigenomic Medicine, Children’s Hospital of Philadelphia and University of Pennsylvania
  • Pilar M. Corena-McLeod, Ph.D., Neuropsycopharmacology Laboratory, Mayo Clinic
  • Noah Walton, Ph.D., Principal Scientist, CNS, Astellas Research Ins
  • Robert L. Elliott, M.D., Ph.D., Elliott-Barnett-Head Breast Cancer Research and Treatment Center
  • Paola Marignani, Ph.D., Associate Professor, Biochemistry and Molecular Biology, Dalhousie University
  • Andreas Wiederkehr, Ph.D., Head, Mitochondrial Research, Nestlé Institute of Health Sciences, Switzerland
  • Jerry R. Colca, Ph.D., President and CSO, Metabolic Solutions Development Company
  • Yvonne Will, Ph.D., Compound Safety Prediction- WWMC, Cell Based Assays and Mitochondrial Biology, Pfizer R&D
  • Nagendra Nadava, Ph.D., Principal Investigator, Pioneer Valley Life Sciences Institute 

 

 
Deadline for Abstracts: ---
 
Registration: Register Now
E-mail: kwaterman@healthtech.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.